SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

Arbutus Biopharma Corp

Arbutus Biopharma is trending as investors focus on the FDA Fast Track designation for its lead hepatitis B candidate, imdusiran, while continuing to speculate on the potential for a multibillion-dollar patent settlement with Pfizer. Community discussion remains heavily centered on institutional accumulation, the stock's significant undervaluation relative to its IP portfolio, and frustration over prolonged periods of price consolidation despite positive clinical and legal developments.

American Bitcoin Corp. engages in the management of a bitcoin accumulation platform. It offers exposure to bitcoin through an industry-first business model that integrates scaled self-mining operations with disciplined accumulation strategies. The company was founded by Eric Trump and Donald John Trump Jr. on October 3, 2018 and is headquartered in Miami, FL.

American Bitcoin Corp. - Ordinary Shares - Class A

American Bitcoin Corp.

American Bitcoin Corp. is facing significant volatility and investor skepticism due to a recent reverse stock split, ongoing dilution concerns, and intense community debates regarding its association with the Trump family and business transparency. While some traders are attempting to play the momentum of its Bitcoin holdings, critics are calling the stock a scam, highlighting its history of reverse splits, minimal revenue, and aggressive dilution as major red flags.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is seeing intense market activity and social media buzz driven by a strategic pivot to discontinue internal discovery programs and focus on external innovation, which investors are interpreting as a potential setup for a corporate buyout. The community remains hyper-focused on elevated short interest, high-volume price action, and rumors of potential acquisition as the company looks to lean out its operations and improve profitability.

T1 Energy, Inc. engages in providing energy solutions focused on solar module and solar cell manufacturing. It focuses on building an integrated U.S. supply chain for solar and batteries. The company was founded by Tom Einar Jensen, Peter Matrai, and Tore Ivar Slettemoen on August 31, 2023 and is headquartered in Austin, TX.

T1 Energy Inc.

T1 Energy is experiencing extreme volatility and heavy community scrutiny following a significant price drop, driven by unsubstantiated regulatory and supply chain rumors that have fueled intense debates between bearish traders and long-term bulls. Investors are closely monitoring technical support levels and awaiting updates on G2 financing, while social sentiment remains polarized between those viewing the decline as a major accumulation opportunity and those concerned about the company's high burn rate and headline risk.

Phoenix Asia Holdings Ltd. engages in the substructure works and other construction services. It offers site formation, ground investigation and foundation work through it subsidiary. The company was founded on August 9, 2024 and is headquartered in Hong Kong.

Phoenix Asia Holdings Ltd.

Phoenix Asia Holdings Ltd. is capturing intense trader attention due to a significant strategic pivot into the pharmaceutical sector through a definitive acquisition agreement with ACEA Pharma. The community is actively debating the stock's extreme volatility and frequent trading halts, with discussions split between those anticipating a major squeeze and critics labeling the movement as a high-risk pump.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

Energy Select Sector SPDR Fund ($XLE) is currently experiencing increased market activity as traders react to highly unusual call option sweepers and ongoing regional instability. The community remains focused on the potential impact of Strait of Hormuz shipping disruptions and the sector's role as a defensive hedge amid broader market uncertainty.

Sony Group Corp. engages in the development, design, manufacture, and sale of electronic equipment, instruments, devices, game consoles, and software for consumers, professionals and industrial markets. It operates through the following segments: Game and Network Services, Music, Pictures, Entertainment Technology & Services, Imaging and Sensing Solutions, Financial Services, and Others. The Game and Network Services segment deals with gaming machines, software and network services. The Music segment produces and publishes music and provides image media platforms. The Pictures segment handles film production, television program creation, and media networks. The Home Entertainment and Sound segment offers LCD televisions, home audio, Blu-ray Disc players and recorders, and memory-based portable audio devices. The Imaging and Sensing Solutions segment includes the image sensors business. The Financial Services segment manages the life insurance and non-life insurance operations and banking business. The Others segment consists of various operating activities, including the disc manufacturing and recording media businesses. The company was founded by Akio Morita and Masaru Ibuka on May 7, 1946 and is headquartered in Tokyo, Japan.

Sony Group Corporation - ADR

Sony Group Corporation

Sony is facing intense scrutiny and community backlash over its shift toward an all-digital gaming ecosystem, fueling widespread debate about the future of physical media and consumer ownership. Meanwhile, investors are closely monitoring the company's financial transition, balancing concerns over gaming division restructuring against excitement for upcoming major franchise releases and its strategic position in the AI hardware market.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending following a massive 20-year, $19 billion lease agreement with Anthropic to provide AI data center capacity, which serves as a major validation of its strategic pivot from crypto mining to AI infrastructure. While the community is debating the stock's volatile price action and potential for institutional manipulation, investors remain highly focused on the company's ability to secure long-term, high-value contracts and the continued expansion of its data center footprint.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing heightened community interest as investors weigh its potential for a short squeeze against significant options activity and ongoing consolidation near technical support levels. While sentiment remains polarized between bulls anticipating a breakout from its recent trading range and skeptics citing lack of immediate catalysts, discourse is heavily focused on the stock's high short interest and its strategic positioning in the AI and robotics sectors.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is facing significant volatility and investor scrutiny as the stock experiences a sharp pullback, further complicated by a newly filed patent infringement lawsuit from Wolfspeed. The community remains deeply divided, with some investors viewing the price decline as a buying opportunity based on long-term conviction in the company's GaN and SiC power technology, while others point to valuation concerns and recent insider activity as signs of a broader correction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SPPI / $ASRT  lost more than 88% after clinical trial failures and FDA setbacks, and the company later agreed to a $15.95M investor settlement. 
 
If you bought or held $SPPI between 2018 and 2021, you may still be able to recover losses from, as late claims are currently being accepted: https://11th.com/cases/spectrum-investor-settlement

Spectrum Pharmaceuticals ($ASRT) has agreed to settle $15.95 million with investors to resolve claims that it misled them about the effectiveness and FDA app...

11th.com

Spectrum Pharmaceuticals (SPPI) $15.95M Investor Settlement

StockTwits Web

Spectrum Pharmaceuticals, Inc.

Assertio Holdings Inc

  lost more than 88% after clinical trial failures and FDA setbacks, and the company later agreed to a $15.95M investor settlement. 
 
If you bought or held 

 between 2018 and 2021, you may still be able to recover losses from, as late claims are currently being accepted: 